Skip to main content
. 2022 Apr 25;29(1):1272–1281. doi: 10.1080/10717544.2022.2027572

Figure 4.

Figure 4.

In vivo inflammation-targeting ability of fucoidan–deoxycholic acid (FD) nanomicelles after in situ dripping. (A) Fluorescence images of the tongue were obtained using an in vivo imaging spectrum system. (B) Semi-quantitative analysis of fluorescence images (n = 3). Data are shown as mean ± SD. (C) Immunofluorescence images of tongues after administration of DOX/FD nanomicelles (blue, nucleus; green, DOX/FD nanomicelles; purple, blood vessels). DOX: doxorubicin. Scale bar, 50 μm.